Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.490 Q1 | 103 | 116 | 280 | 14411 | 1277 | 246 | 4.05 | 124.23 | |
2 | Open AIDS Journal | journal | 1.235 Q1 | 22 | 18 | 58 | 754 | 141 | 54 | 3.03 | 41.89 | |
3 | Current Alzheimer Research | journal | 1.145 Q2 | 103 | 134 | 394 | 9083 | 1226 | 359 | 2.98 | 67.78 | |
4 | Current Gene Therapy | journal | 1.008 Q1 | 80 | 41 | 139 | 3484 | 338 | 128 | 2.16 | 84.98 | |
5 | Current Medicinal Chemistry | journal | 0.918 Q1 | 202 | 332 | 835 | 40345 | 2886 | 780 | 3.22 | 121.52 | |
6 | Current Topics in Medicinal Chemistry | journal | 0.878 Q1 | 133 | 242 | 775 | 22746 | 2415 | 671 | 3.09 | 93.99 | |
7 | Current Cancer Drug Targets | journal | 0.875 Q1 | 103 | 87 | 227 | 8117 | 521 | 202 | 2.15 | 93.30 | |
8 | Current Drug Targets | journal | 0.825 Q2 | 119 | 171 | 558 | 16711 | 1326 | 491 | 2.22 | 97.73 | |
9 | Current Molecular Pharmacology | journal | 0.774 Q2 | 49 | 34 | 99 | 2857 | 178 | 83 | 1.22 | 84.03 | |
10 | Current Genomics | journal | 0.765 Q3 | 77 | 65 | 153 | 6155 | 367 | 132 | 2.06 | 94.69 | |
11 | CNS and Neurological Disorders - Drug Targets | journal | 0.747 Q2 | 96 | 87 | 433 | 6391 | 937 | 373 | 2.32 | 73.46 | |
12 | Current Diabetes Reviews | journal | 0.733 Q2 | 68 | 59 | 156 | 4300 | 350 | 139 | 2.16 | 72.88 | |
13 | Current Pharmaceutical Design | journal | 0.703 Q2 | 183 | 567 | 1815 | 57632 | 4871 | 1663 | 2.46 | 101.64 | |
14 | Current Drug Abuse Reviews | journal | 0.683 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
15 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.656 Q3 | 63 | 79 | 125 | 4874 | 255 | 117 | 1.28 | 61.70 | |
16 | Current Neurovascular Research | journal | 0.625 Q3 | 60 | 47 | 146 | 2068 | 281 | 133 | 1.64 | 44.00 | |
17 | Mini-Reviews in Medicinal Chemistry | journal | 0.609 Q2 | 107 | 124 | 419 | 9892 | 1022 | 373 | 2.49 | 79.77 | |
18 | Current Vascular Pharmacology | journal | 0.605 Q2 | 69 | 106 | 251 | 7332 | 481 | 202 | 1.90 | 69.17 | |
19 | Current Protein and Peptide Science | journal | 0.599 Q2 | 96 | 116 | 296 | 11924 | 552 | 253 | 1.52 | 102.79 | |
20 | Current Stem Cell Research and Therapy | journal | 0.595 Q2 | 63 | 70 | 227 | 6906 | 444 | 199 | 2.08 | 98.66 | |
21 | Current Rheumatology Reviews | journal | 0.530 Q3 | 29 | 42 | 82 | 1863 | 180 | 79 | 1.66 | 44.36 | |
22 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.529 Q2 | 52 | 33 | 88 | 3586 | 192 | 82 | 2.10 | 108.67 | |
23 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.528 Q3 | 108 | 218 | 518 | 13123 | 1043 | 487 | 1.91 | 60.20 | |
24 | Clinical Practice and Epidemiology in Mental Health | journal | 0.528 Q2 | 58 | 33 | 67 | 1467 | 129 | 66 | 1.70 | 44.45 | |
25 | Current Clinical Pharmacology | journal | 0.522 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
26 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.521 Q2 | 28 | 0 | 43 | 0 | 85 | 38 | 1.79 | 0.00 | |
27 | MicroRNA (Shariqah, United Arab Emirates) | journal | 0.520 Q2 | 29 | 26 | 67 | 0 | 111 | 66 | 1.44 | 0.00 | |
28 | Current Cardiology Reviews | journal | 0.516 Q2 | 58 | 39 | 126 | 2319 | 218 | 114 | 1.29 | 59.46 | |
29 | Current Organic Chemistry | journal | 0.489 Q3 | 112 | 176 | 550 | 18526 | 1048 | 484 | 1.81 | 105.26 | |
30 | Open Neuroimaging Journal | journal | 0.483 Q2 | 9 | 12 | 19 | 682 | 25 | 17 | 1.32 | 56.83 | |
31 | Current Aging Science | journal | 0.476 Q3 | 42 | 32 | 109 | 1679 | 152 | 98 | 1.35 | 52.47 | |
32 | Medicinal Chemistry | journal | 0.475 Q3 | 50 | 80 | 264 | 3667 | 485 | 256 | 1.78 | 45.84 | |
33 | Reviews on Recent Clinical Trials | journal | 0.427 Q3 | 35 | 44 | 135 | 2311 | 131 | 120 | 1.00 | 52.52 | |
34 | Open Respiratory Medicine Journal | journal | 0.420 Q3 | 25 | 8 | 37 | 251 | 55 | 34 | 0.71 | 31.38 | |
35 | Open Cardiovascular Medicine Journal | journal | 0.411 Q3 | 32 | 10 | 74 | 384 | 100 | 72 | 1.23 | 38.40 | |
36 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.405 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
37 | Current Drug Delivery | journal | 0.402 Q2 | 72 | 139 | 346 | 7811 | 572 | 325 | 1.54 | 56.19 | |
38 | Current Drug Discovery Technologies | journal | 0.397 Q3 | 49 | 32 | 72 | 1739 | 137 | 70 | 1.17 | 54.34 | |
39 | Current Organic Synthesis | journal | 0.377 Q3 | 55 | 83 | 239 | 6372 | 379 | 224 | 1.70 | 76.77 | |
40 | Current Drug Safety | journal | 0.371 Q3 | 41 | 40 | 131 | 1071 | 158 | 120 | 1.27 | 26.78 | |
41 | Recent Patents on Nanotechnology | journal | 0.370 Q1 | 36 | 22 | 75 | 1811 | 124 | 63 | 1.40 | 82.32 | |
42 | Combinatorial Chemistry and High Throughput Screening | journal | 0.367 Q3 | 70 | 95 | 287 | 3519 | 379 | 253 | 1.43 | 37.04 | |
43 | Open Dentistry Journal | journal | 0.366 Q3 | 37 | 124 | 249 | 3877 | 283 | 241 | 1.10 | 31.27 | |
44 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.351 Q3 | 39 | 22 | 92 | 1459 | 96 | 77 | 0.97 | 66.32 | |
45 | Infectious Disorders - Drug Targets | journal | 0.351 Q3 | 61 | 34 | 83 | 1174 | 85 | 74 | 0.87 | 34.53 | |
46 | Current Nanoscience | journal | 0.336 Q2 | 52 | 65 | 285 | 2563 | 407 | 259 | 1.51 | 39.43 | |
47 | Drug Metabolism Letters | journal | 0.312 Q2 | 31 | 20 | 74 | 622 | 64 | 65 | 0.88 | 31.10 | |
48 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.307 Q3 | 43 | 24 | 61 | 1300 | 55 | 52 | 1.03 | 54.17 | |
49 | Emirates Journal of Food and Agriculture | journal | 0.307 Q3 | 43 | 126 | 358 | 5202 | 404 | 354 | 1.13 | 41.29 | |
50 | Current Psychiatry Reviews | journal | 0.303 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®